Teva Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Teva Pharma (TEVA) CEO says they have no plans to issue equity to reduce debt
May 3, 2018 8:32 AM EDTOn call, Teva Pharma (NYSE: TEVA) CEO says they have no plans to issue equity to reduce debt
Teva Pharma (TEVA) Tops Q1 EPS by 28c, Raises FY Guidance
May 3, 2018 7:02 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $0.94, $0.28 better than the analyst estimate of $0.66. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.8 billion.
GUIDANCE:
Teva Pharma sees FY2018 EPS of $2.40-$2.65, versus the consensus... More
